Radiopharmaceuticals Market Research Report - Forecast till 2027

Radiopharmaceuticals Market: Information by Type (Diagnostic (SPECT Radiopharmaceuticals, PET Radiopharmaceuticals) and Therapeutic), Application (Neurology, Cardiology, Oncology and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/1119-CR | February, 2021 | Region : Global

Radiopharmaceuticals Market overview 


Nuclear medicine is a revolutionary therapy in the healthcare sector. Nuclear medicine therapy using radiopharmaceuticals is gaining popularity every year. It is a medication that contains radioisotopes that used as both a diagnosis medication and a therapeutic agent. The advancements in this sector have to lead to plenty of successful treatments. Radio-pharmaceuticals are a therapy that manages both chronic and critical diseases. Radio-pharmaceuticals are widely used in molecular imaging as a biomarker. Also, there are several diagnostics for targeted organ with nuclear medicine radiopharmaceuticals.


 During the radiopharmaceuticals, the SPECT and the PET techniques are widely used. The cost-effectiveness, noninvasiveness, high sensitivity and ease of diagnosis are some of the specialties of radiopharmaceuticals. The clinical applications of radiopharmaceuticals are oncology, cardiology, thyroid, tumour and lymphoma. Radiopharmaceuticals are popular due to their low-cost diagnosis. Due to all these benefits of radiopharmaceuticals, its requirement is increasing in the medical field. As per the pharmaceutical market research reports, the growth rate of this radiopharmaceuticals market is expected to be 8.10%. Also, the pharmaceutical market value is estimated as 15.060.87 during the forecast year 2025. 


Covid analysis 


Covid 19 outbreak has caused several damages to most of the global industries. In the medical sector, there is massive research happening to find an effective vaccine for the virus. There is wide use of different pharmaceutical products during the pandemic. The radiopharmaceuticals market size is growing due to the virus outbreak. The surging trends will continue till the forecast year 2025. Early detection of radiopharmaceuticals is helping health advisers to diagnose any illness at the primary stage. It is assisting the health advisers to provide quick treatments for heart, bone and cancer patients. During the covid 19, the market faced several disruptions in the demand and supply of the product. The manufacturing process is resuming that increases the demand for the radiopharmaceuticals market. Moreover, the requirement for radiopharmaceuticals has grown due to the prevalence of online pharmacy services. 


Market dynamics 



  • The crucial market drivers 


The radiopharmaceutical is considered the fastest-growing segment in the pharmaceutical industry. The increasing awareness about the early and timely diagnosis by radiopharmaceutical therapy is the crucial radiopharmaceuticals market driver. Today, radiopharmaceuticals are widely used to diagnose chronic illness. The prevalence of chronic illness is high due to the unhealthy lifestyle of individuals. Also, the positive results of radiopharmaceutical in treating this chronic illness are driving more demand for the radiopharmaceuticals market.


Moreover, the versatile application of radiopharmaceuticals is another crucial market driving factor for this radiopharmaceuticals market. Through immense research and development, the healthcare industry can use radiopharmaceuticals for plenty of medical reasons. The high R&D is constantly developing the radiopharmaceutical market. Moreover, the technological advancement in the medical field is another factor that fuels the demand for radiopharmaceuticals. This high-end therapy is essential to treat chronic diseases at an early stage. With the advancing technological innovation in medical devices, the demand for radiopharmaceuticals grows in the forecast period. 



  • The market growth opportunities 


The radiopharmaceutical market has plenty of new product launches and developments. The robust development offers tons of future radiopharmaceutical market growth opportunities. Due to the prevalence of cancer, there is high demand for nuclear imaging technology. There are new types of radiopharmaceuticals that enable the diagnosis of cancer and oncology.


Also, the pharmaceutical applications of radioisotopes are increasingly contributing to further growth opportunities. These factors in the market offer promising growth opportunities in the upcoming years. Several key players in the radiopharmaceuticals market are creating future growth opportunities by providing new developments. Also, the key players are planning to launch the new therapeutics of radiopharmaceuticals in the next year. Moreover, the developments of medical infrastructure in many regions accelerate the growth opportunities. With the rising infrastructural development, the use of radiopharmaceuticals will be more prevalent. 



  • The market restraints 


The slow adoption rate of radiopharmaceuticals is a major restraint in this radiopharmaceuticals market. Radiopharmaceuticals are a high-end technology. It is can easily detect chronic illness and help in early diagnosis. The market needs to increase the product awareness. The lack of awareness is causing less adoption rate in this market. The less adoption rate of this technology can slow down the overall growth rate of the radiopharmaceuticals market.


Moreover, the half-life of radiopharmaceuticals is another restraining factor in this market. Radiopharmaceuticals are a high investment. The half-life or the short expectancy of it is a crucial factor that restricts the radiopharmaceuticals market demand. Many purchasers are hesitant due to the low life expectancy of the technology. As per the pharmaceutical market report, the restraints demand a declining effect on the radiopharmaceutical market during the forecast period. 



  • The market challenges  


With high-end technology, individuals expect cost-effectiveness. The function of radiopharmaceuticals is exceptional. However, the high cost poses a major challenge to this radiopharmaceuticals market. Only the developed regions can adapt to radiopharmaceuticals due to high spending power. However, the undeveloped regions and small medical firms find it difficult to afford the product. The cost of radiopharmaceuticals can slightly decline the radiopharmaceuticals market growth in the forecast period. 



  • The cumulative growth analysis 


Radiopharmaceutical is a surging market with plenty of growth potentials. The radiopharmaceuticals market drivers will contribute more to the overall market development during the forecast year. The growth Opportunities of this market look promising. In the upcoming years, the adoption rate of radiopharmaceuticals will substantially grow. However, there is a serious need to fix the cost challenges in this market. The radiopharmaceuticals market requires cost-effectiveness to attract customers from all regions. Also, there is a need to accelerate the awareness of radiopharmaceuticals in the upcoming years. As per the radiopharmaceutical market analysis, the market shows a positive trend that will continue till the forecast year 2025. 



  • The value chain analysis 


North America holds the largest radiopharmaceutical market share. The adoption rate of nuclear medicine is high in this region. Also, the usage of advanced therapeutic technologies is growing in this region. Also, North America is well known for its high purchasing power. All these factors are contributing to the massive growth rate of radiopharmaceuticals in this region. Moreover, the prevalence of cancer and cardiovascular are propelling the overall growth of the US radiopharmaceutical company. The well established key players in this region are launching a new product and expanding the radiopharmaceuticals market during the forecast year. 


Market segment 


By product 



  • TL-201

  • I-123

  • TC-99m

  • GA-67

  • SR-82/RB-82

  • F-18

  • RA-223

  • Re-186

  • Lu-117

  • I-131

  • SM-153

  • Y-90

  • Iridium-192

  • Cesium-131

  • Iodine-125

  • Palladium-103


By application 



  • Endocrine Tumor

  • Neurology

  • Bone Metastasis

  • Oncology

  • Lymphoma

  • Thyroid


Regional outlook 


North America 



  • Canada

  • S


Asia pacific 



  • India

  • South Korea

  • China 

  • Japan 

  • Singapore 

  • Malaysia 

  • New Zealand 


Middle East 



  • Turkey 

  • Saudi Arabia 

  • Israel 

  • South Africa 


Latin America 



  • Mexico 

  • Argentina 

  • Brazil 


Europe 



  • Spain 

  • France 

  • Germany 

  • UK 

  • Russia 

  • Netherlands 

  • Italy 


Regional analysis 


The radiopharmaceutical market is diversified into North America, Asia Pacific, Middle East, Latin America and Europe. High R&D investments are the crucial factor for the overall growth in the regional market. Also, Europe is a highly developing market with more research on medical isotopes.


The governmental support in the European region is driving more demand for the radiopharmaceuticals market. Also, the Asia Pacific is the fastest growing regional market. The increasing geriatric rate is raising the demand for nuclear medicine in this region. The Middle East and the Latin American region are the fastest emerging markets in the radiopharmaceuticals industry. The regional players are making several product innovations in radiopharmaceuticals. Some of the key players in this market are taking plenty of cost-cutting measures to increase the growth rate during the forecast period. 


Competitive landscape 


The radiopharmaceutical market is less competitive. However, the entry of new radiopharmaceutical companies will make the market more competitive in the upcoming years. The key market players are planning several market acquisitions and expansion plans in the upcoming years. 


The key players of the radiopharmaceutical market are 



  • GE healthcare 

  • Cardinal health 

  • Jubilant life sciences

  • Norgine B.V 

  • Curium 

  • Bracco diagnostic   

  • Lantheus Medical imaging 

  • Novartis AG 

  • Siemens healthiness 

  • JSC isotopes 

  • Curium 

  • Australian Nuclear Science and Technology


Recent developments 



  • The Lantheus is acquired as the leading imaging and diagnosis centre in this region. It is a step to expand their market in the forecast period. 

  • The radioisotope in Japan announces several new partnerships around the country. The specializing technologies are used in several chronic disease diagnostic procedures.

  • The key players of the market are expanding the research of radiopharmaceutical technology. It is a measure to widen the application uses of the technology.  


Report overview 



  1. Market overview highlights 

  2. Analysis based upon COVID 19

  3. Explanation upon the Market Dynamics

  4. Value chain analysis

  5. Market segmentation overview

  6. The regional analysis

  7. Competitive landscape analysis

  8. Recent Developments

1 EXECUTIVE SUMMARY

1 OVERVIEW 23

1.1.1 MARKET SYPNOSIS 23

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 24

2.2 RESEARCH OBJECTIVE 24

2.3 LIST OF ASSUMPTIONS 24

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 26

3.2 DATA MINING 26

3.2.1 SECONDARY RESEARCH 27

3.2.2 PRIMARY RESEARCH 28

3.2.3 FORECASTING METHODS 29

3.3 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 31

3.3.1 BOTTOM-UP APPROACH 31

3.3.2 TOP-DOWN APPROACH 32

3.4 DATA TRIANGULATION 33

3.5 VALIDATION 33

4 MARKET DYNAMICS

4.1 OVERVIEW 34

4.2 DRIVERS 35

4.2.1 GROWING APPLICATION OF RADIOISOTOPES IN THE HEALTHCARE INDUSTRY 35

4.2.2 INCREASING USE OF RADIOPHARMACEUTICALS FOR THE DIAGNOSIS & TREATMENT OF CHRONIC DISEASES 35

4.2.3 TECHNOLOGICAL ADVANCEMENTS IN THE DIAGNOSTICS SECTOR 36

4.3 RESTRAINTS 37

4.3.1 SHORT HALF-LIFE OF RADIOPHARMACEUTICALS 37

4.3.2 HIGH COST OF RADIOPHARMACEUTICALS 37

4.4 OPPORTUNITY 38

4.4.1 TECHNOLOGICAL ADVANCEMENTS IN RADIOPHARMACEUTICAL OR MEDICINAL RADIO COMPOUNDS 38

5 MARKET FACTOR ANALYSIS

5.1 GLOBAL RADIOPHARMACEUTICALS MARKET: SUPPLY CHAIN ANALYSIS 39

5.1.1 NUCLEAR RESEARCH REACTORS (NRRS) 39

5.1.2 PROCESSORS 40

5.1.3 GENERATOR MANUFACTURERS 41

5.1.4 NUCLEAR PHARMACIES 41

5.1.5 PATIENTS AND HEALTH CARE PROVIDERS 41

5.2 PORTER’S FIVE FORCES MODEL 42

5.2.1 THREAT OF NEW ENTRANTS 43

5.2.2 BARGAINING POWER OF SUPPLIERS 43

5.2.3 BARGAINING POWER OF BUYERS 43

5.2.4 THREAT OF SUBSTITUTES 44

5.2.5 INTENSITY OF RIVALRY 44

6 RADIOPHARMACEUTICALS MARKET, BY TYPE

6.1 OVERVIEW 45

6.2 DIAGNOSTICS 46

6.3 THERAPEUTIC 48

7 RADIOPHARMACEUTICALS MARKET, BY APPLICATION

7.1 OVERVIEW 49

7.2 NEUROLOGY 50

7.3 CARDIOLOGY 51

7.4 ONCOLOGY 52

7.5 OTHERS 52

8 GLOBAL RADIOPHARMACEUTICALS MARKET, BY REGION

8.1 OVERVIEW 53

8.2 AMERICAS 54

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.1 NORTH AMERICA 57

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.1.1 US 59

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.1.2 CANADA 61

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2 LATIN AMERICA 63

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.1 BRAZIL 65

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.2 ARGENTINA 67

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.3 MEXICO 69

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.4 COLOMBIA 70

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.5 CHILE 72

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.6 PERU 74

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.7 URUGUAY 75

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.8 VENEZUELA 77

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.2.2.9 REST OF LATIN AMERICA 79

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION


8.3 EUROPE 81

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1 WESTERN EUROPE 84

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.1 GERMANY 86

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.2 FRANCE 88

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.3 SWITZERLAND 90

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.4 NETHERLAND 91

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.5 BELGIUM 93

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.6 AUSTRIA 95

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.7 ITALY 96

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.1.8 SPAIN 98

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.2 NORTHERN EUROPE 100

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.2.1 UK 102

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.2.2 NORWAY 104

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.2.3 SWEDEN 105

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.2.4 IRELAND 107

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.2.5 DENMARK 109

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.3 EASTERN EUROPE 111

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.3.1 RUSSIA 113

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.3.2 POLAND 115

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.3.3 CZECH REPUBLIC 116

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.3.4 ROMANIA 118

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.3.5 HUNGARY 120

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.3.4 REST OF EUROPE 122

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4 ASIA-PACIFIC 124

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.1 CHINA 127

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.2 JAPAN 128

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.3 INDIA 130

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.4 AUSTRALIA 132

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5 SOUTH EAST ASIA 134

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5.1 MALAYSIA 136

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5.2 THAILAND 138

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5.3 INDONESIA 139

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5.4 SINGAPORE 141

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5.5 VIETNAM 143

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.5.6 PHILIPPINES 144

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.6 SOUTH KOREA 146

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.7 NEW ZEALAND 148

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.8 PAKISTAN 149

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.4.9 REST OF ASIA-PACIFIC 151

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5 MIDDLE EAST & AFRICA 153

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.1 SAUDI ARABIA 155

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.2 UNITED ARAB EMIRATES 157

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.3 OMAN 159

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.4 QATAR 160

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.5 KUWAIT 162

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.6 TURKEY 164

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.7 SOUTH AFRICA 165

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.8 EGYPT 167

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.9 NIGERIA 169

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

8.5.10 REST OF MIDDLE EAST & AFRICA 170

RADIOPHARMACEUTICALS MARKET, BY TYPE

RADIOPHARMACEUTICALS MARKET, BY APPLICATION

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 173

9.2 GLOBAL RADIOPHARMACEUTICALS MARKET: MAJOR PLAYERS 173

10 COMPANY PROFILES

10.1 GE HEALTHCARE 175

10.1.1 COMPANY OVERVIEW 175

10.1.2 FINANCIAL OVERVIEW 176

10.1.3 PRODUCTS/SERVICES OFFERED 176

10.1.4 GE HEALTHCARE: KEY DEVELOPMENTS 177

10.1.5 SWOT ANALYSIS 177

10.1.6 KEY STRATEGIES 177

10.2 LANTHEUS MEDICAL IMAGING, INC. 178

10.2.1 COMPANY OVERVIEW 178

10.2.2 FINANCIAL OVERVIEW 178

10.2.3 PRODUCTS/SERVICES OFFERED 179

10.2.4 KEY DEVELOPMENTS 179

10.2.5 SWOT ANALYSIS 179

10.2.6 KEY STRATEGIES 179


10.3 NOVARTIS AG 180

10.3.1 COMPANY OVERVIEW 180

10.3.2 FINANCIAL OVERVIEW 180

10.3.3 PRODUCTS/SERVICES OFFERED 181

10.3.4 KEY DEVELOPMENTS 181

10.3.5 SWOT ANALYSIS 182

10.3.6 KEY STRATEGIES 182

10.4 BWX TECHNOLOGIES, INC. 183

10.4.1 COMPANY OVERVIEW 183

10.4.2 FINANCIAL OVERVIEW 183

10.4.3 PRODUCTS/SERVICES OFFERED 184

10.4.4 KEY DEVELOPMENTS 184

10.4.5 SWOT ANALYSIS 185

10.4.6 KEY STRATEGIES 185

10.5 SIEMENS HEALTHINEERS 186

10.5.1 COMPANY OVERVIEW 186

10.5.2 FINANCIAL OVERVIEW 186

10.5.3 PRODUCTS/SERVICES OFFERED 187

10.5.4 KEY DEVELOPMENTS 187

10.5.5 SWOT ANALYSIS 188

10.5.6 KEY STRATEGIES 188

10.6 IRE ELIT 189

10.6.1 COMPANY OVERVIEW 189

10.6.2 FINANCIAL OVERVIEW 189

10.6.3 PRODUCTS/SERVICES OFFERED 189

10.6.4 KEY DEVELOPMENTS 190

10.6.5 SWOT ANALYSIS 190

10.6.6 KEY STRATEGIES 190

10.7 JSC ISOTOPE 191

10.7.1 COMPANY OVERVIEW 191

10.7.2 FINANCIAL OVERVIEW 191

10.7.3 PRODUCTS/SERVICES OFFERED 192

10.7.4 KEY DEVELOPMENTS 192

10.7.5 SWOT ANALYSIS 193

10.7.6 KEY STRATEGIES 193


10.8 NTP RADIOISOTOPES SOC LTD 194

10.8.1 COMPANY OVERVIEW 194

10.8.2 FINANCIAL OVERVIEW 194

10.8.3 PRODUCTS/SERVICES OFFERED 195

10.8.4 KEY DEVELOPMENTS 195

10.8.5 SWOT ANALYSIS 196

10.8.6 KEY STRATEGIES 196

10.9 CURIUM 197

10.9.1 COMPANY OVERVIEW 197

10.9.2 FINANCIAL OVERVIEW 197

10.9.3 PRODUCTS/SERVICES OFFERED 197

10.9.4 KEY DEVELOPMENTS 198

10.9.5 SWOT ANALYSIS 199

10.9.6 KEY STRATEGIES 199

10.10 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION (ANSTO) 200

10.10.1 COMPANY OVERVIEW 200

10.10.2 FINANCIAL OVERVIEW 200

10.10.3 PRODUCTS/SERVICES OFFERED 200

10.10.4 KEY DEVELOPMENTS 201

10.10.5 SWOT ANALYSIS 201

10.10.6 KEY STRATEGIES 201

11 APPENDIX

11.1 REFERENCES 202

11.2 RELATED REPORTS 202

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 24

TABLE 2 PRODUCTION CAPACITY OF NUCLEAR RESEARCH REACTOR IRRADIATORS IN INDUSTRY, BY COUNTRY 40

TABLE 3 PRODUCTION CAPACITY OF PROCESSORS IN INDUSTRY, BY COUNTRY 40

TABLE 4 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 46

TABLE 5 GLOBAL RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION,

2020–2027 (USD MILLION) 46

TABLE 6 GLOBAL RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 46

TABLE 7 GLOBAL RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 8 GLOBAL RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 9 GLOBAL RADIOPHARMACEUTICALS MARKET, FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION,

2020–2027 (USD MILLION) 48

TABLE 10 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 50

TABLE 11 GLOBAL RADIOPHARMACEUTICALS MARKET FOR NEUROLOGY, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 12 GLOBAL RADIOPHARMACEUTICALS MARKET FOR CARDIOLOGY, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 13 GLOBAL RADIOPHARMACEUTICALS MARKET FOR ONCOLOGY, BY REGION, 2020–2027 (USD MILLION) 52

TABLE 14 GLOBAL RADIOPHARMACEUTICALS MARKET, BY REGION, 2020–2027 (USD MILLION) 54

TABLE 15 AMERICAS: RADIOPHARMACEUTICALS MARKET, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 16 AMERICAS: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 55

TABLE 17 AMERICAS: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 55

TABLE 18 AMERICAS: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 56

TABLE 19 AMERICAS: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 56

TABLE 20 AMERICAS: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56

TABLE 21 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 57

TABLE 22 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 23 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 58

TABLE 24 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 58

TABLE 25 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 58

TABLE 26 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 59

TABLE 27 US: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 28 US: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 29 US: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 30 US: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 31 US: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 32 CANADA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 33 CANADA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 61

TABLE 34 CANADA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 61

TABLE 35 CANADA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 62

TABLE 36 CANADA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 37 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 63

TABLE 38 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 39 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 64

TABLE 40 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 64

TABLE 41 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 65

TABLE 42 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 43 BRAZIL: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 44 BRAZIL: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 66

TABLE 45 BRAZIL: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 46 BRAZIL: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 47 BRAZIL: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 67

TABLE 48 ARGENTINA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 49 ARGENTINA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 67

TABLE 50 ARGENTINA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 68

TABLE 51 ARGENTINA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 68

TABLE 52 ARGENTINA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 53 MEXICO: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 54 MEXICO: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 69

TABLE 55 MEXICO: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 56 MEXICO: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 57 MEXICO: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 58 COLOMBIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 59 COLOMBIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 71

TABLE 60 COLOMBIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 71

TABLE 61 COLOMBIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 71

TABLE 62 COLOMBIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72

TABLE 63 CHILE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 64 CHILE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 72

TABLE 65 CHILE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 66 CHILE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 67 CHILE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 73

TABLE 68 PERU: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 69 PERU: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 74

TABLE 70 PERU: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 74

TABLE 71 PERU: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 72 PERU: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 73 URUGUAY: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 74 URUGUAY: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 76

TABLE 75 URUGUAY: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 76 URUGUAY: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 77 URUGUAY: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77

TABLE 78 VENEZUELA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 79 VENEZUELA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 77

TABLE 80 VENEZUELA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 78

TABLE 81 VENEZUELA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 78

TABLE 82 VENEZUELA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 78

TABLE 83 REST OF LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 84 REST OF LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 79

TABLE 85 REST OF LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 79

TABLE 86 REST OF LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 80

TABLE 87 REST OF LATIN AMERICA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 88 EUROPE: RADIOPHARMACEUTICALS MARKET, BY REGION, 2020–2027 (USD MILLION) 81

TABLE 89 EUROPE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 90 EUROPE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 82

TABLE 91 EUROPE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 92 EUROPE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 93 EUROPE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 94 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84

TABLE 95 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 96 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 85

TABLE 97 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 85

TABLE 98 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 86

TABLE 99 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 100 GERMANY: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 101 GERMANY: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 87

TABLE 102 GERMANY: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 103 GERMANY: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 104 GERMANY: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 88

TABLE 105 FRANCE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 106 FRANCE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 88

TABLE 107 FRANCE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 108 FRANCE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 109 FRANCE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 110 SWITZERLAND: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 111 SWITZERLAND: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 90

TABLE 112 SWITZERLAND: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 90

TABLE 113 SWITZERLAND: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 91

TABLE 114 SWITZERLAND: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91

TABLE 115 NETHERLANDS: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 116 NETHERLANDS: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 92

TABLE 117 NETHERLANDS: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 92

TABLE 118 NETHERLANDS: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 92

TABLE 119 NETHERLANDS: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93

TABLE 120 BELGIUM: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 121 BELGIUM: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 93

TABLE 122 BELGIUM: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 94

TABLE 123 BELGIUM: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 124 BELGIUM: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 94

TABLE 125 AUSTRIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 126 AUSTRIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 95

TABLE 127 AUSTRIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 95

TABLE 128 AUSTRIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 129 AUSTRIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96

TABLE 130 ITALY: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 131 ITALY: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 97

TABLE 132 ITALY: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 133 ITALY: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 134 ITALY: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 98

TABLE 135 SPAIN: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 136 SPAIN: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 98

TABLE 137 SPAIN: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 99

TABLE 138 SPAIN: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 139 SPAIN: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99

TABLE 140 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100

TABLE 141 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 142 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 101

TABLE 143 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 101

TABLE 144 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 101

TABLE 145 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 102

TABLE 146 UK: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 147 UK: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 148 UK: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 149 UK: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 150 UK: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103

TABLE 151 NORWAY: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 152 NORWAY: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 104

TABLE 153 NORWAY: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 154 NORWAY: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 155 NORWAY: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 156 SWEDEN: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 157 SWEDEN: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 106

TABLE 158 SWEDEN: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 159 SWEDEN: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 160 SWEDEN: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107

TABLE 161 IRELAND: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 162 IRELAND: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 107

TABLE 163 IRELAND: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 164 IRELAND: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 165 IRELAND: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 108

TABLE 166 DENMARK: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 167 DENMARK: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 109

TABLE 168 DENMARK: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 109

TABLE 169 DENMARK: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 110

TABLE 170 DENMARK: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110

TABLE 171 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111

TABLE 172 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 173 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 112

TABLE 174 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 112

TABLE 175 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 112

TABLE 176 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 113

TABLE 177 RUSSIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 178 RUSSIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 113

TABLE 179 RUSSIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 180 RUSSIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 181 RUSSIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 114

TABLE 182 POLAND: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 183 POLAND: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 115

TABLE 184 POLAND: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 185 POLAND: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 186 POLAND: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 116

TABLE 187 CZECH REPUBLIC: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 188 CZECH REPUBLIC: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 117

TABLE 189 CZECH REPUBLIC: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 117

TABLE 190 CZECH REPUBLIC: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 117

TABLE 191 CZECH REPUBLIC: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118

TABLE 192 ROMANIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 193 ROMANIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 118

TABLE 194 ROMANIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 119

TABLE 195 ROMANIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 119

TABLE 196 ROMANIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 119

TABLE 197 HUNGARY: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120

TABLE 198 HUNGARY: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 120

TABLE 199 HUNGARY: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 120

TABLE 200 HUNGARY: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 201 HUNGARY: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121

TABLE 202 REST OF EUROPE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 203 REST OF EUROPE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 122

TABLE 204 REST OF EUROPE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 122

TABLE 205 REST OF EUROPE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 123

TABLE 206 REST OF EUROPE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123

TABLE 207 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, BY REGION, 2020–2027 (USD MILLION) 125

TABLE 208 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 125

TABLE 209 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 125

TABLE 210 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 126

TABLE 211 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 126

TABLE 212 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 126

TABLE 213 CHINA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 214 CHINA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 127

TABLE 215 CHINA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 216 CHINA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 128

TABLE 217 CHINA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128

TABLE 218 JAPAN: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 128

TABLE 219 JAPAN: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 129

TABLE 220 JAPAN: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 129

TABLE 221 JAPAN: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 129

TABLE 222 JAPAN: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130

TABLE 223 INDIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 130

TABLE 224 INDIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 130

TABLE 225 INDIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 131

TABLE 226 INDIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 131

TABLE 227 INDIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131

TABLE 228 AUSTRALIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132

TABLE 229 AUSTRALIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 132

TABLE 230 AUSTRALIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 132

TABLE 231 AUSTRALIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 133

TABLE 232 AUSTRALIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 133

TABLE 233 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134

TABLE 234 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134

TABLE 235 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 135

TABLE 236 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 135

TABLE 237 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 135

TABLE 238 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 136

TABLE 239 MALAYSIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136

TABLE 240 MALAYSIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 136

TABLE 241 MALAYSIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 137

TABLE 242 MALAYSIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 137

TABLE 243 MALAYSIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137

TABLE 244 THAILAND: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138

TABLE 245 THAILAND: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 138

TABLE 246 THAILAND: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 138

TABLE 247 THAILAND: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 139

TABLE 248 THAILAND: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139

TABLE 249 INDONESIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139

TABLE 250 INDONESIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 140

TABLE 251 INDONESIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 140

TABLE 252 INDONESIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 140

TABLE 253 INDONESIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 141

TABLE 254 SINGAPORE: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 141

TABLE 255 SINGAPORE: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 141

TABLE 256 SINGAPORE: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 142

TABLE 257 SINGAPORE: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 142

TABLE 258 SINGAPORE: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142

TABLE 259 VIETNAM: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143

TABLE 260 VIETNAM: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 143

TABLE 261 VIETNAM: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 143

TABLE 262 VIETNAM: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 144

TABLE 263 VIETNAM: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 144

TABLE 264 PHILIPPINES: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144

TABLE 265 PHILIPPINES: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 145

TABLE 266 PHILIPPINES: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 145

TABLE 267 PHILIPPINES: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 145

TABLE 268 PHILIPPINES: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 146

TABLE 269 SOUTH KOREA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 146

TABLE 270 SOUTH KOREA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 146

TABLE 271 SOUTH KOREA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 147

TABLE 272 SOUTH KOREA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 147

TABLE 273 SOUTH KOREA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 147

TABLE 274 NEW ZEALAND: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148

TABLE 275 NEW ZEALAND: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 148

TABLE 276 NEW ZEALAND: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 148

TABLE 277 NEW ZEALAND: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 149

TABLE 278 NEW ZEALAND: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 149

TABLE 279 PAKISTAN: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149

TABLE 280 PAKISTAN: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 150

TABLE 281 PAKISTAN: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 150

TABLE 282 PAKISTAN: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 150

TABLE 283 PAKISTAN: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 151

TABLE 284 REST OF ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151

TABLE 285 REST OF ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 151

TABLE 286 REST OF ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 152

TABLE 287 REST OF ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 152

TABLE 288 REST OF ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 152

TABLE 289 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 153

TABLE 290 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154

TABLE 291 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 154

TABLE 292 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 154

TABLE 293 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 155

TABLE 294 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155

TABLE 295 SAUDI ARABIA: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155

TABLE 296 SAUDI ARABIA: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 156

TABLE 297 SAUDI ARABIA: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 156

TABLE 298 SAUDI ARABIA: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 156

TABLE 299 SAUDI ARABIA: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 157

TABLE 300 UNITED ARAB EMIRATES: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157

TABLE 301 UNITED ARAB EMIRATES: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS

BY TYPE, 2020–2027 (USD MILLION) 157

TABLE 302 UNITED ARAB EMIRATES: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS

BY TYPE, 2020–2027 (USD MILLION) 158

TABLE 303 UNITED ARAB EMIRATES: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS

BY TYPE, 2020–2027 (USD MILLION) 158

TABLE 304 UNITED ARAB EMIRATES: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158

TABLE 305 OMAN: RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159

TABLE 306 OMAN: RADIOPHARMACEUTICALS MARKET, FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 159

TABLE 307 OMAN: RADIOPHARMACEUTICALS MARKET, FOR SPECT RADIOPHARMACEUTICALS BY TYPE,

2020–2027 (USD MILLION) 159

TABLE 308 OMAN: RADIOPHARMACEUTICALS MARKET, FOR PET RADIOPHARMACEUTICALS BY TYPE, 2020–2027 (USD MILLION) 160

TABLE 309 OMAN: RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160

TABLE 310 QATAR:

13 LIST OF FIGURES

FIGURE 1 GLOBAL RADIOPHARMACEUTICALS MARKET: MARKET STRUCTURE 25

FIGURE 2 BREAKDOWN OF PRIMARY RESPONDENTS 29

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 31

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL RADIOPHARMACEUTICAL MARKET 34

FIGURE 5 DRIVERS ANALYSIS 36

FIGURE 6 RESTRAINTS ANALYSIS 37

FIGURE 7 SUPPLY CHAIN: GLOBAL RADIOPHARMACEUTICALS MARKET 39

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL RADIOPHARMACEUTICALS MARKET 42

FIGURE 9 GLOBAL RADIOPHARMACEUTICALS MARKET SHARE, BY TYPE, 2020 (%) 45

FIGURE 10 GLOBAL RADIOPHARMACEUTICALS MARKET, BY TYPE, 2020 AND 2027 (USD MILLION) 45

FIGURE 11 GLOBAL RADIOPHARMACEUTICALS MARKET SHARE, BY APPLICATION, 2020 (%) 49

FIGURE 12 GLOBAL RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2020 AND 2027 (USD MILLION) 49

FIGURE 13 GLOBAL RADIOPHARMACEUTICALS MARKET SHARE, BY REGION, 2020 (%) 53

FIGURE 14 GLOBAL RADIOPHARMACEUTICALS MARKET, BY REGION, 2020 AND 2027 (USD MILLION) 53

FIGURE 15 AMERICAS: RADIOPHARMACEUTICALS MARKET SHARE, BY REGION, 2020 (%) 54

FIGURE 16 NORTH AMERICA: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 57

FIGURE 17 LATIN AMERICA: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 63

FIGURE 18 EUROPE: RADIOPHARMACEUTICALS MARKET SHARE, BY REGION, 2020 (%) 81

FIGURE 19 WESTERN EUROPE: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 84

FIGURE 20 NORTHEN EUROPE: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 100

FIGURE 21 EASTERN EUROPE: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 111

FIGURE 22 ASIA-PACIFIC: RADIOPHARMACEUTICALS MARKET SHARE, BY REGION, 2020 (%) 124

FIGURE 23 SOUTH EAST ASIA: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 134

FIGURE 24 MIDDLE EAST & AFRICA: RADIOPHARMACEUTICALS MARKET SHARE, BY COUNTRY, 2020 (%) 153

FIGURE 25 MAJOR MANUFACTURERS: GLOBAL RADIOPHARMACEUTICALS MARKET, 2020 (%) 173

FIGURE 26 GE HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT 176

FIGURE 27 GE HEALTHCARE: SWOT ANALYSIS 177

FIGURE 28 LANTHEUS MEDICAL IMAGING, INC.: FINANCIAL OVERVIEW SNAPSHOT 178

FIGURE 29 LANTHEUS MEDICAL IMAGING, INC.: SWOT ANALYSIS 179

FIGURE 30 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 180

FIGURE 31 NOVARTIS AG: SWOT ANALYSIS 182

FIGURE 32 BWX TECHNOLOGIES, INC.: FINANCIAL OVERVIEW SNAPSHOT 183

FIGURE 33 BWX TECHNOLOGIES, INC.: SWOT ANALYSIS 185

FIGURE 34 SIEMENS: FINANCIAL OVERVIEW SNAPSHOT 186

FIGURE 35 SIEMENS HEALTHINEERS: SWOT ANALYSIS 188

FIGURE 36 IRE ELIT: SWOT ANALYSIS 190

FIGURE 37 JSC ISOTOPE: FINANCIAL OVERVIEW 191


FIGURE 38 JSC ISOTOPE: SWOT ANALYSIS 193

FIGURE 39 NTP RADIOISOTOPES SOC LTD: FINANCIAL OVERVIEW 194

FIGURE 40 NTP RADIOISOTOPES SOC LTD: SWOT ANALYSIS 196

FIGURE 41 CURIUM: SWOT ANALYSIS 199

FIGURE 42 AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANIZATION (ANSTO): SWOT ANALYSIS 201

Radio Pharmaceutical Market